World Intellectual Property Organization
The present invention relates to new proteins comprising fibroblast growth factor 2 1 (FGF21 ) and other metabolic regulators known to improve metabolic profiles in subjects to whom they are administered.
Boettcher, Brian R.; Caplan, Shari L.; Cellitti, Susan E.; Daniels, Douglas S.; Hamamatsu, Norio; Geierstanger, Bernhard Hubert; Licht, Stuart; Loew, Andreas; and Weldon, Stephen Craig, "Patent: Dual Function Proteins for Treating Metabolic Disorders" (2013). Chemistry Faculty Publications. 103.